triazoles has been researched along with Becker Muscular Dystrophy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bottino, C; Caretti, G; Filippakopoulos, P; Fittipaldi, R; Mamchaoui, K; Nevi, L; Segatto, M; Szokoll, R | 1 |
| De Moor, O; Dorgan, CR; Johnson, PD; Lambert, AG; Lecci, C; Maillol, C; Nugent, G; Poignant, SD; Price, PD; Pye, RJ; Storer, R; Tinsley, JM; Vickers, R; Well, Rv; Wilkes, FJ; Wilson, FX; Wren, SP; Wynne, GM | 1 |
2 other study(ies) available for triazoles and Becker Muscular Dystrophy
| Article | Year |
|---|---|
BETs inhibition attenuates oxidative stress and preserves muscle integrity in Duchenne muscular dystrophy.
Topics: Animals; Azepines; Disease Models, Animal; Inflammation; Mice; Mice, Inbred C57BL; Mice, Inbred mdx; Muscle, Skeletal; Muscular Dystrophy, Duchenne; NADP; NADPH Oxidases; Neuromuscular Diseases; Nuclear Proteins; Oxidative Stress; Reactive Oxygen Species; Transcription Factors; Triazoles | 2020 |
Discovery and SAR of 2-arylbenzotriazoles and 2-arylindazoles as potential treatments for Duchenne muscular dystrophy.
Topics: Dose-Response Relationship, Drug; Drug Discovery; Humans; Indazoles; Microsomes, Liver; Molecular Structure; Muscular Dystrophy, Duchenne; Solubility; Stereoisomerism; Structure-Activity Relationship; Triazoles | 2011 |